Correction: Mixed Hepatocellular–Cholestatic Liver Injury after Pioglitazone Therapy. Ann Intern Med. 2002;136:711. doi: 10.7326/0003-4819-136-9-200205070-00025
Download citation file:
Published: Ann Intern Med. 2002;136(9):711.
In a recent summary for patients (1) that accompanied the paper by May and colleagues (2), the section “What are the implications of the study?” should read “Liver damage may occur in patients who take pioglitazone. Patients who are taking this drug should have periodic blood tests to check liver function. If patients develop new symptoms while taking pioglitazone, they should contact their doctors.”
Learn more about subscription options.
Register Now for a free account.
Copyright © 2016 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use
This PDF is available to Subscribers Only